FDA Drug Information Updates

FDA Drug Information Updates

by

Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.

Recent Episodes

  • The FAERS Public Dashboard and its Value to the Pharmaceutical Industry

    6 years ago
  • FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)

    6 years ago
  • FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

    6 years ago
  • FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents

    6 years ago
  • FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk

    6 years ago
  • Pinpointing the Top Questions about Biosimilars in Rheumatology

    6 years ago
  • The FDA's Adverse Event Reporting System (FAERS) Public Dashboard

    6 years ago
  • FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

    7 years ago
  • FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

    7 years ago
  • FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer

    7 years ago